You are here

Tissue-specific mechanisms control the retention of IL-8 in lungs and skin.

TitleTissue-specific mechanisms control the retention of IL-8 in lungs and skin.
Publication TypeJournal Article
Year of Publication2002
AuthorsFrevert, CW, Goodman, RB, Kinsella, MG, Kajikawa, O, Ballman, K, Clark-Lewis, I, Proudfoot, AEI, Wells, TNC, Martin, TR
JournalJ Immunol
Volume168
Issue7
Pagination3550-6
Date Published2002 Apr 1
ISSN0022-1767
KeywordsAnimals, Female, Injections, Intradermal, Injections, Intravenous, Interleukin-8, Intubation, Intratracheal, Iodine Radioisotopes, Lung, Neutropenia, Neutrophil Infiltration, Organ Specificity, Rabbits, Skin, Vinblastine
Abstract

Chemokines are a group of structurally related peptides that promote the directed migration of leukocytes in tissue. Mechanisms controlling the retention of chemokines in tissue are not well understood. In this study we present evidence that two different mechanisms control the persistence of the CXC chemokine, IL-8, in lungs and skin. (125)I-labeled IL-8 was injected into the airspaces of the lungs and the dermis of the skin and the amount of (125)I-labeled IL-8 that remained at specified times was measured by scintillation counting. The (125)I-labeled IL-8 was cleared much more rapidly from skin than lungs, as only 2% of the (125)I-labeled IL-8 remained in skin at 4 h whereas 50% of the (125)I-labeled IL-8 remained in lungs at 4 h. Studies in neutropenic rabbits showed that neutrophils shortened the retention of (125)I-labeled IL-8 in skin but not lungs. A monomeric form of IL-8, N-methyl-leucine 25 IL-8, was not retained as long in lungs as recombinant human IL-8, indicating that dimerization of IL-8 is a mechanism that increases the local concentration and prolongs the retention of (125)I-labeled IL-8 in lungs. These observations show that the mechanisms that control the retention of IL-8 in tissue include neutrophil migration and dimerization, and that the importance of these varies in different tissues.

Alternate JournalJ. Immunol.
PubMed ID11907118
Grant ListAI29103 / AI / NIAID NIH HHS / United States
R21 RR030249-02 / RR / NCRR NIH HHS / United States